July 31, 2017 - By Kurt Siggers
Among 4 analysts covering Koninklijke DSM (OTCMKTS:RDSMY), 3 have Buy rating, 0 Sell and 1 Hold. Therefore 75% are positive. Koninklijke DSM had 5 analyst reports since August 6, 2015 according to SRatingsIntel. Bank of America upgraded Koninklijke DSM N.V. (ADR) (OTCMKTS:RDSMY) on Wednesday, October 14 to “Buy” rating. The rating was downgraded by Liberum Capital on Monday, November 9 to “Hold”. The firm has “Buy” rating by Berenberg given on Thursday, August 6. The rating was upgraded by ABN Amro to “Buy” on Thursday, October 8. The firm earned “Buy” rating on Thursday, October 1 by Liberum Capital. See Koninklijke DSM N.V. (ADR) (OTCMKTS:RDSMY) latest ratings:
Analysts expect Real Industry Inc (NASDAQ:RELY) to report $-0.31 EPS on August, 8.They anticipate $0.23 EPS change or 287.50% from last quarter’s $-0.08 EPS. After having $-0.43 EPS previously, Real Industry Inc’s analysts see -27.91% EPS growth. It closed at $2.8 lastly. It is down 55.90% since July 31, 2016 and is downtrending. It has underperformed by 72.60% the S&P500.
Real Industry, Inc. is a holding company. The company has market cap of $83.43 million. The Firm focuses on the activities of Real Alloy Holding, Inc. , which is engaged in aluminum recycling. It currently has negative earnings. The Company’s divisions include Real Alloy North America (RANA) and Real Alloy Europe (RAEU).
Koninklijke DSM N.V. is a global science company, engaged in offering health, nutrition and materials. The company has market cap of $13.36 billion. The Company’s divisions include Nutrition, Performance Materials, Innovation Center and Corporate Activities. It has a 15.47 P/E ratio. The Company’s Nutrition segment includes DSM Nutritional Products and DSM Food Specialties.
The stock increased 0.40% or $0.07 on July 28, reaching $18.28. About 23,267 shares traded. Koninklijke DSM N.V. (ADR) (OTCMKTS:RDSMY) has 0.00% since July 31, 2016 and is . It has underperformed by 16.70% the S&P500.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.